154 related articles for article (PubMed ID: 3703359)
1. [The role of the urinary hydroxyproline level in the screening for collagen diseases].
Gambella GR; Zunino M
Minerva Med; 1986 Apr; 77(16):607-12. PubMed ID: 3703359
[TBL] [Abstract][Full Text] [Related]
2. [A method of fractionating urinary peptides containing hydroxyproline].
Borel JP; Caranjot JM; Jayle MF
Clin Chim Acta; 1967 Jun; 16(3):409-16. PubMed ID: 6035187
[No Abstract] [Full Text] [Related]
3. [Rarefying osteopathy in rheumatology. Methods of evaluation and comparison of urinary hydroxyproline and serum proline iminopeptidase].
D'Amore M; Quarto S; Terlizzi N; Martiradonna A; Carrozzo M
Minerva Med; 1980 Jul; 71(29):2045-51. PubMed ID: 6967571
[TBL] [Abstract][Full Text] [Related]
4. The urinary excretion of inorganic pyrophosphate in hyperparathyroidism, hyperthyroidism, Paget's disease and other disorders of bone metabolism.
Russell RG; Hodgkinson A
Clin Sci; 1969 Jun; 36(3):435-43. PubMed ID: 4307562
[No Abstract] [Full Text] [Related]
5. [Modifications of peptide hydroxyprolinuria during Paget's disease and osteoma (author's transl)].
Dakkak R; Goussault Y; Dreux C
Ann Biol Clin (Paris); 1979; 37(4):195-200. PubMed ID: 525849
[TBL] [Abstract][Full Text] [Related]
6. [Deoxypyridinoline and other biochemical markers of bone resorption in distinct pathologies].
Rivero Marcotegui A; Palacios Sarrasqueta M; Grijalba Uche A; Martínez Rodríguez JL; Sorbet Zubiría MJ; García Merlo S
Rev Clin Esp; 1997 Jun; 197(6):389-92. PubMed ID: 9304127
[TBL] [Abstract][Full Text] [Related]
7. [Valve and significance of urinary hydroxyproline in osseous pathology].
Hioco D; Gruson M; Ryckewaert A; de Sèze S
Ann Biol Clin (Paris); 1967; 25(5):725-34. PubMed ID: 6059731
[No Abstract] [Full Text] [Related]
8. [Hydroxyprolinuria in Paget's disease of bone].
Recordier AM; Eisinger JB; Moulard JC
Mars Med; 1970; 107(3):231-3. PubMed ID: 5455741
[No Abstract] [Full Text] [Related]
9. [Hydroxyproline excretion in urine in chronic connective tissue disease].
Emmrich R
Z Gesamte Inn Med; 1970 Dec; 25(23):1062-5. PubMed ID: 4397769
[No Abstract] [Full Text] [Related]
10. Relation between urine zinc and hydroxyproline in rheumatoid arthritis and bone diseases.
Ambanelli U; Ferraccioli GF; Bernardi P; Servemti G
J Rheumatol; 1978; 5(4):477-9. PubMed ID: 739496
[No Abstract] [Full Text] [Related]
11. [Indications for urinary hydroxyproline determination].
Burkhardt H; Wepler R; Rommel K
Dtsch Med Wochenschr; 1976 Sep; 101(38):1394-7. PubMed ID: 782814
[No Abstract] [Full Text] [Related]
12. [Chromatographic analysis of urinary amino acids in Paget's disease. I : Biochemical study. Isolation and amino acid composition of a urinary peptide specific to this bone disease].
Fabier JL; Viau M; Constans J; Clerc A
Rev Rhum Mal Osteoartic; 1976 Apr; 43(4):249-53. PubMed ID: 1273474
[TBL] [Abstract][Full Text] [Related]
13. Urinary excretion of glycosaminoglycans and hydroxyproline in Paget's disease of bone, compared with neoplastic invasion of bone.
Bower L; Manley G
J Clin Pathol; 1981 Oct; 34(10):1097-101. PubMed ID: 7309892
[TBL] [Abstract][Full Text] [Related]
14. [Urinary hydroxyproline excretion in generalized bone diseases].
Czitober H; Raab W
Wien Z Inn Med; 1967; 48(10):401-8. PubMed ID: 5620579
[No Abstract] [Full Text] [Related]
15. [The clinical significance of hydroxyproline in the urine].
Emmrich R; Häntzschel HJ; Häntzschel H
Z Gesamte Inn Med; 1967 Apr; 22(7):193-9. PubMed ID: 5596343
[No Abstract] [Full Text] [Related]
16. [Determination of serum proline iminopeptidase activity using a fluorescent substrate in patients with Paget's disease and prostatic bone metastases. Preliminary results].
Bouvier M; Colson F; Tebib J; Mathieu M; Vianey-Liaud C
Pathol Biol (Paris); 1986 Apr; 34(4):235-9. PubMed ID: 3528996
[TBL] [Abstract][Full Text] [Related]
17. [Hydroxyprolinuria in skeletal diseases: its correlation with other parameters of bone metabolism].
Courvoisier B; Zender R
Schweiz Med Wochenschr; 1972 Feb; 102(5):160-6. PubMed ID: 5010800
[No Abstract] [Full Text] [Related]
18. Relevance of urinary excretion of alcian blue-glycosaminoglycans complexes and hydroxyproline to disease activity in rheumatoid arthritis.
Mbuyi JM; Dequeker J; Teblick M; Merlevede M
J Rheumatol; 1982; 9(4):579-83. PubMed ID: 7131456
[TBL] [Abstract][Full Text] [Related]
19. [Hydroxyproline excretion in the urine in Paget's osteodystrophia deformans. Comparative clinical, morphological and biochemical studies].
Raab W; Czitober H
Wien Klin Wochenschr; 1967 Feb; 79(5):91-3. PubMed ID: 5591364
[No Abstract] [Full Text] [Related]
20. [Clinical significance of urinary hydroxyproline excretion in rheumatoid arthritis].
Weimann G; Burkhardt H; Rommel K
Verh Dtsch Ges Rheumatol; 1972; 2():Suppl 2:119-23. PubMed ID: 5051938
[No Abstract] [Full Text] [Related]
[Next] [New Search]
